Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
6.36
-0.09 (-1.40%)
At close: Nov 20, 2024, 4:00 PM
6.33
-0.03 (-0.47%)
After-hours: Nov 20, 2024, 7:54 PM EST
Ginkgo Bioworks Holdings Employees
Ginkgo Bioworks Holdings had 1,218 employees as of December 31, 2023. The number of employees decreased by 74 or -5.73% compared to the previous year.
Employees
1,218
Change (1Y)
-74
Growth (1Y)
-5.73%
Revenue / Employee
$178,942
Profits / Employee
-$534,638
Market Cap
354.32M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1,218 | -74 | -5.73% |
Dec 31, 2022 | 1,292 | 651 | 101.56% |
Dec 31, 2021 | 641 | 146 | 29.49% |
Dec 31, 2020 | 495 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Cross Country Healthcare | 13,131 |
Enhabit | 10,800 |
Valneva SE | 676 |
Amylyx Pharmaceuticals | 384 |
AirSculpt Technologies | 381 |
Kamada | 378 |
Omeros | 198 |
MaxCyte | 143 |
DNA News
- 2 days ago - Ginkgo Bioworks: Unproven Transition But 2025 Is Looking Better - Seeking Alpha
- 7 days ago - Ginkgo Bioworks: Not Enough Progress - Seeking Alpha
- 8 days ago - Ginkgo Bioworks Holdings, Inc. (DNA) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Ginkgo Bioworks Reports Third Quarter 2024 Financial Results - PRNewsWire
- 8 days ago - Ginkgo Bioworks Advances Collaboration with Merck to Improve Biologics Manufacturing - PRNewsWire
- 16 days ago - Ginkgo Bioworks Announces Date of Third Quarter 2024 Results Presentation - PRNewsWire
- 6 weeks ago - Ginkgo Bioworks (DNA) Shares Drop Amid Weak Earnings and Sell Ratings - GuruFocus
- 7 weeks ago - Virica Biotech and Ginkgo Bioworks Announce Partnership to Accelerate AAV Gene Therapy Manufacturing - Business Wire